<p>，/PRNewswire/ -- Ademi 律师事务所正在调查 Quipt（纳斯达克：QIPT）在其最近宣布与 Kingswood 和 Forager 的交易中可能存在的信托责任违反和其他法律违规行为。</p>
<p>点击这里了解如何加入我们的调查并获取更多信息，或通过 [email protected] 与我们联系，或拨打免费电话：866-264-3995。对您没有任何费用或义务。</p>
<p>在此次交易中，Quipt 股东将获得每股 3.65 美元的回报，Quipt 的估值约为 2.6 亿美元，包括 Quipt 现有的未偿债务。Quipt 内部人士将作为控制权变更安排的一部分获得可观的利益。</p>
<p>交易协议不合理地限制了 Quipt 的竞争交易，若 Quipt 接受竞争报价将面临重大罚款。我们正在调查 Quipt 董事会的行为，以及他们是否履行了对所有股东的信托责任。</p>
<p>我们专注于涉及收购、合并和个人股东权利的股东诉讼。如需更多信息，请随时致电我们。律师广告。以往的结果并不保证类似的结果。</p>
<p>联系方式</p>
<p>Ademi &amp; Fruchter LLP</p>
<p>Guri Ademi</p>
<p>免费电话：（866）264-3995</p>
<p>传真：（414）482-8001</p>
<p>来源：Ademi LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE2Jk5ld3NJdGVtSWQ9Q0c0ODYwNCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTYxMDQ3UFJfTkVXU19VU1BSX19fX19DRzQ4NjA0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE2Jk5ld3NJdGVtSWQ9Q0c0ODYwNCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTYxMDQ3UFJfTkVXU19VU1BSX19fX19DRzQ4NjA0"/></p>

QIPT

<p>Ademi 律师事务所正在调查 Quipt Home Medical Corp.在与 Kingswood 和 Forager 的交易中是否存在潜在的信托责任违规行为。Quipt 的股东将获得每股 3.65 美元，公司的估值为 2.6 亿美元。该交易通过设定罚款限制了竞争性投标，而 Quipt 的内部人士则从控制权变更安排中获益。调查的重点是 Quipt 董事会是否履行了对股东的信托责任</p>

<p>, /PRNewswire/ -- The Ademi Firm is investigating Quipt (Nasdaq: QIPT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Kingswood and Forager.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Ademi 律师事务所正在调查 Quipt（纳斯达克：QIPT）在其最近宣布与 Kingswood 和 Forager 的交易中可能存在的信托责任违反和其他法律违规行为。</p>
</div><p>Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.</p>
<div class="lb-trans"><p>点击这里了解如何加入我们的调查并获取更多信息，或通过 [email protected] 与我们联系，或拨打免费电话：866-264-3995。对您没有任何费用或义务。</p>
</div><p>In the transaction, Quipt shareholders will receive $3.65 per share, valuing Quipt at approximately $260 million, including Quipt's existing outstanding debt. Quipt insiders will receive substantial benefits as part of change of control arrangements.</p>
<div class="lb-trans"><p>在此次交易中，Quipt 股东将获得每股 3.65 美元的回报，Quipt 的估值约为 2.6 亿美元，包括 Quipt 现有的未偿债务。Quipt 内部人士将作为控制权变更安排的一部分获得可观的利益。</p>
</div><p>The transaction agreement unreasonably limits competing transactions for Quipt by imposing a significant penalty if Quipt accepts a competing bid. We are investigating the conduct of the Quipt board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.</p>
<div class="lb-trans"><p>交易协议不合理地限制了 Quipt 的竞争交易，若 Quipt 接受竞争报价将面临重大罚款。我们正在调查 Quipt 董事会的行为，以及他们是否履行了对所有股东的信托责任。</p>
</div><p>We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>我们专注于涉及收购、合并和个人股东权利的股东诉讼。如需更多信息，请随时致电我们。律师广告。以往的结果并不保证类似的结果。</p>
</div><p>Contacts</p>
<div class="lb-trans"><p>联系方式</p>
</div><p>Ademi &amp; Fruchter LLP</p>
<div class="lb-trans"><p>Ademi &amp; Fruchter LLP</p>
</div><p>Guri Ademi</p>
<div class="lb-trans"><p>Guri Ademi</p>
</div><p>Toll Free: (866) 264-3995</p>
<div class="lb-trans"><p>免费电话：（866）264-3995</p>
</div><p>Fax: (414) 482-8001</p>
<div class="lb-trans"><p>传真：（414）482-8001</p>
</div><p>SOURCE Ademi LLP</p>
<div class="lb-trans"><p>来源：Ademi LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE2Jk5ld3NJdGVtSWQ9Q0c0ODYwNCZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTYxMDQ3UFJfTkVXU19VU1BSX19fX19DRzQ4NjA0" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG48604&amp;Transmission_Id=202512161047PR_NEWS_USPR_____CG48604&amp;DateId=20251216"/></p>

10:47 ET
			
			
				Shareholder Alert: The Ademi Firm investigates whether Quipt Home Medical Corp. is obtaining a Fair Price for its Public Shareholders

股东警示：Ademi 公司正在调查 Quipt Home Medical Corp.是否为其公众股东争取到了公平的价格